Cerebrospinal fluid markers in Creutzfeldt-Jakob disease

Cerebrospinal Fluid Research

Volumn 5, Issue , 2008, Pages

  Skinningsrud, Anders ^a   Stenset, Vidar ^a,b   Gundersen, Astrid S ^a,b   Fladby, Tormod ^a,b  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; PROTEIN 14 3 3; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; IMMUNOBLOTTING; MALE; MULTIINFARCT DEMENTIA; NEUROLOGIC DISEASE; NORWAY; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 51649089626     PISSN: 17438454     EISSN: None     Source Type: Journal    
DOI: 10.1186/1743-8454-5-14     Document Type: Article

References (15)

1. Ladogana A Puopolo M Croes EA Budka H Jarius C Collins S Klug GM Sutcliffe T Giulivi A Alperovitch A Delasnerie-Laupretre N Brandel JP Poser S Kretzschmar H Rietveld I Mitrova E Cuesta Jde P Martinez-Martin P Glatzel M Aguzzi A Knight R Ward H Pocchiari M van Duijn CM Will RG Zerr I Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada Neurology 2005, 64:1586-1591. 10.1212/ 01.WNL.0000160117.56690.B2 15883321
2. Collinge J Molecular neurology of prion disease J Neurol Neurosurg Psychiat 2005, 76:906-919. 1739714 15965195 10.1136/jnnp.2004.048660
3. Benestad SL Sarradin P Thu B Schonheit J Tranulis MA Bratberg B Cases of scrapie with unusual features in Norway and designation of a new type, Nor98 Vet Rec 2003, 153:202-208. 12956297
4. Otto M Wiltfang J Tumani H Zerr I Lantsch M Kornhuber J Weber T Kretzschmar HA Poser S Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease Neurosci Lett 1997, 225:210-212. 10.1016/S0304-3940(97)00215-2 9147407
5. Strozyk D Blennow K White LR Launer LJ CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study Neurology 2003, 60:652-656. 12601108
6. Rank KB Pauley AM Bhattacharya K Wang Z Evans DB Fleck TJ Johnston JA Sharma SK Direct interaction of soluble human recombinant tau protein with Abeta 1-42 results in tau aggregation and hyperphosphorylation by tau protein kinase II FEBS Lett 2002, 514:263-268. 10.1016/ S0014-5793(02)02376-1 11943163
7. Riemenschneider M Wagenpfeil S Vanderstichele H Otto M Wiltfang J Kretzschmar H Vanmechelen E Forstl H Kurz A Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias Mol Psychiatry 2003, 8:343-347. 10.1038/sj.mp.4001220 12660807
8. Satoh K Shirabe S Eguchi H Tsujino A Eguchi K Satoh A Tsujihata M Niwa M Katamine S Kurihara S Matsuo H 14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan Cell Mol Neurobiol 2006, 26(1):45-52. 16633900 10.1007/s10571-006-9370-z
9. Van Everbroeck B Green AJ Vanmechelen E Vanderstichele H Pals P Sanchez-Valle R Corrales NC Martin JJ Cras P Phosphorylated tau in cerebrospinal fluid as a marker for Creutzfeldt-Jakob disease J Neurol Neurosurg Psychiat 2002, 73:79-81. 1757299 12082054 10.1136/jnnp.73.1.79
10. World Health Organization Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: Report from a WHO consultation Emerging and Other Communicable Diseases, Surveillance and Control Geneva, Switzerland: World Health Organization 1998, 1-26.
11. Sanchez-Juan P Green A Ladogana A Cuadrado-Corrales N Saanchez-Valle R Mitrovaa E Stoeck K Sklaviadis T Kulczycki J Hess K Bodemer M Slivarichova D Saiz A Calero M Ingrosso L Knight R Janssens AC van Duijn CM Zerr I CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease Neurology 2006, 67:637-643. 10.1212/01.wnl.0000230159.67128.00 16924018
12. Sjogren M Vanderstichele H Agren H Zachrisson O Edsbagge M Wikkelso C Skoog I Wallin A Wahlund LO Marcusson J Nagga K Andreasen N Davidsson P Vanmechelen E Blennow K Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: Establishment of reference values Clin Chem 2001, 47:1776-1781. 11568086
13. Stenset V Johnsen L Kocot D Negaard A Skinningsrud A Gulbrandsen P Wallin A Fladby T Associations between white matter lesions, cerebrovascular risk factors, and low CSF Abeta42 Neurology 2006, 67:830-833. 10.1212/01.wnl.0000234030.77831.5a 16966546
14. Buerger K Otto M Teipel SJ Zinkowski R Blennow K DeBernardis J Kerkman D Schroder J Schonknecht P Cepek L McCulloch C Moller HJ Wiltfang J Kretzschmar H Hampel H Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease Neurobiol Aging 2006, 27:10-15. 10.1016/j.neurobiolaging.2004.12.003 16298235
15. Riemenschneider M Klopp N Xiang W Wagenpfeil S Vollmert C Muller U Forstl H Illig T Kretzschmar H Kurz A Prion protein codon 129 polymorphism and risk of Alzheimer disease Neurology 2004, 63:364-366. 15277640